Bioactive peptide of marine origin for the prevention and treatment of non-communicable diseases

Marine Drugs

Volumn 15, Issue 3, 2017, Pages

  Pangestuti, Ratih ^a   Kim, Se Kwon ^b,c  

^a INDONESIAN INSTITUTE OF SCIENCES   (Indonesia)

^b Pukyong National University   (South Korea)

^c Institute of Life Science (ILSS) Kolmar Korea Co   (South Korea)

Author keywords

Bioactive peptide; Marine; Non communicable diseases; Prevention; Treatment

Indexed keywords

AE 941; ALANYLLYSYLTYROSYLSERYLTYROSINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; APRATOXIN A; ASPARTYLPROLINE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISCODERMIN; GEODIOMOLIDE; GLYCYLPROPYLLEUCINE; HALICYLINDRAMIDE; HEMIASTERLIN; ISOLEUCYLALANYLPROPYLGLYCINE; ISOLEUCYLARGINYLLEUCYLISOLEUCYLISOLEUCYLVALYLLEUCYLMETHIONYLPROPYLISOLEUCYLLEUCYLMETHIONYLALANINE; ISOLEUCYLLYSYLTRYPTOPHAN; ISOLEUCYLTRYPTOPHAN; ISOLEUCYLTYROSINE; JASPAMIDE; LEUCYLARGINYLPROLINE; LEUCYLHISTIDINYLPROLINE; MARINE COLLAGEN PEPTIDE; OLIGOPEPTIDE; PARDAXIN; PEPTIDE; RENIN INHIBITOR; SERYLTHREONINE; TALTOBULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALYLTRYPTOPHAN; BIOLOGICAL FACTOR;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; CARDIOVASCULAR DISEASE; CRUSTACEA; CYANOBACTERIUM; DIABETES MELLITUS; DRUG STRUCTURE; ENZYME INHIBITION; FISH; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALIGNANT NEOPLASM; MARINE SPECIES; MOLLUSC; NON COMMUNICABLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEAWEED; SOLID TUMOR; SPONGE (PORIFERA); UROCHORDATA; ANIMAL; AQUATIC SPECIES; CHEMISTRY; NEOPLASM; RESPIRATORY TRACT DISEASE;

ANIMALS; AQUATIC ORGANISMS; BIOLOGICAL FACTORS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; NEOPLASMS; PEPTIDES; RESPIRATORY TRACT DISEASES;

EID: 85016476393     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md15030067     Document Type: Review

References (155)

1. World Health Organization. Global Status Report on Noncommuniacble Diseases; World Health Organization: Genève, Switzerland, 2014; p. 280.
2. World Health Organization. Global Status Report on Noncommunicable Diseases; World Health Organization: Genève, Switzerland, 2010; p. 162.
3. Bhandari, G.P.; Angdembe, M.R.; Dhimal, M.; Neupane, S.; Bhusal, C. State of non-communicable diseases in Nepal. BMC Public Health 2014, 14, 23. [CrossRef] [PubMed]
4. Collins, K.G.; Fitzgerald, G.F.; Stanton, C.; Ross, R.P. Looking Beyond the Terrestrial: The Potential of Seaweed Derived Bioactives to Treat Non-Communicable Diseases. Mar. Drugs 2016, 14, 60. [CrossRef] [PubMed]
5. Wagner, K.-H.; Brath, H. A global view on the development of non communicable diseases. Prev. Med. 2012, 54, S38-S41. [CrossRef] [PubMed]
6. Erdmann, K.; Cheung, B.W.Y.; Schröder, H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J. Nutr. Biochem. 2008, 19, 643-654. [CrossRef] [PubMed]
7. Kris-Etherton, P.M.; Hecker, K.D.; Bonanome, A.; Coval, S.M.; Binkoski, A.E.; Hilpert, K.F.; Griel, A.E.; Etherton, T.D. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113 (Suppl. 9), 71S-88S. [CrossRef]
8. Wijesekara, I.; Pangestuti, R.; Kim, S.K. Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydr. Polym. 2010, 84, 14-21. [CrossRef]
9. Pangestuti, R.; Kim, S.-K. Biological activities and health benefit effects of natural pigments derived from marine algae. J. Funct. Foods 2011, 3, 255-266. [CrossRef]
10. Yusuf, S.; Wood, D.; Ralston, J.; Reddy, K.S. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet 2015, 386, 399-402. [CrossRef]
11. Nichols, M.; Townsend, N.; Scarborough, P.; Rayner, M. Cardiovascular disease in Europe 2014: Epidemiological update. Eur. Heart J. 2014, 35, 2950-2959. [CrossRef] [PubMed]
12. Kearney, P.M.; Whelton, M.; Reynolds, K.; Muntner, P.; Whelton, P.K.; He, J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005, 365, 217-223. [CrossRef]
13. Himaya, S.; Ngo, D.-H.; Ryu, B.; Kim, S.-K. An active peptide purified from gastrointestinal enzyme hydrolysate of Pacific cod skin gelatin attenuates angiotensin-1 converting enzyme (ACE) activity and cellular oxidative stress. Food Chem. 2012, 132, 1872-1882. [CrossRef]
14. Kher, V. Renin inhibition-Benefit beyond hypertension control. J. Assoc. Phys. India 2009, 57, 518-521.
15. Allikmets, K. Aliskiren-An orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension. Vasc. Health Risk Manag. 2007, 3, 809. [PubMed]
16. Fitzgerald, C.N.; Mora-Soler, L.; Gallagher, E.; O'Connor, P.; Prieto, J.; Soler-Vila, A.; Hayes, M. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata. J. Agric. Food Chem. 2012, 60, 7421-7427. [CrossRef] [PubMed]
17. Fitzgerald, C.; Aluko, R.E.; Hossain, M.; Rai, D.K.; Hayes, M. Potential of a renin inhibitory peptide from the red seaweed Palmaria palmata as a functional food ingredient following confirmation and characterization of a hypotensive effect in spontaneously hypertensive rats. J. Agric. Food Chem. 2014, 62, 8352-8356. [CrossRef] [PubMed]
18. Suetsuna, K.; Maekawa, K.; Chen, J.-R. Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. J. Nutr. Biochem. 2004, 15, 267-272. [CrossRef] [PubMed]
19. Fitzgerald, C.; Gallagher, E.; Doran, L.; Auty, M.; Prieto, J.; Hayes, M. Increasing the health benefits of bread: Assessment of the physical and sensory qualities of bread formulated using a renin inhibitory Palmaria palmata protein hydrolysate. LWT Food Sci. Technol. 2014, 56, 398-405. [CrossRef]
20. Suetsuna, K.; Osajika, K. The inhibitroy activity of angiotensin-1 converting enzyme of basic peptides from sardine and hair tail meat. Bull. Jpn. Soc. Sci. Fish. 1986, 52, 1981-1984. [CrossRef]
21. Kim, S.; Wijesekara, I. Development and biological activities of marine-derived bioactive peptides: A review. J. Funct. Foods 2010, 2, 1-9. [CrossRef]
22. Wijesekara, I.; Kim, S.K. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Mar. Drugs 2010, 8, 1080-1093. [CrossRef] [PubMed]
23. Nakamura, Y.; Yamamoto, N.; Sakai, K.; Okubo, A.; Yamazaki, S.; Takano, T. Purification and Characterization of Angiotensin I-Converting Enzyme Inhibitors from Sour Milk. J. Dairy Sci. 1995, 78, 777-783. [CrossRef]
24. Ariyoshi, Y. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Technol. 1993, 4, 139-144. [CrossRef]
25. Suetsuna, K.; Nakano, T. Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J. Nutr. Biochem. 2000, 11, 450-454. [CrossRef]
26. Nomura, A.; Noda, N.; Maruyama, S. Purification of angiotensin I-converting enzyme inhibitors in pelagic thresher Alopias pelagicus muscle hydrolysate and viscera extracts. Fish. Sci. 2002, 68, 954-956. [CrossRef]
27. Ikeda, A.; Ichino, H.; Kiguchiya, S.; Chigwechokha, P.; Komatsu, M.; Shiozaki, K. Evaluation and Identification of Potent Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Dwarf Gulper Shark (Centrophorus atromarginatus). J. Food Process. Preserv. 2015, 39, 107-115. [CrossRef]
28. Wu, H.; He, H.-L.; Chen, X.-L.; Sun, C.-Y.; Zhang, Y.-Z.; Zhou, B.-C. Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate. Proc. Biochem. 2008, 43, 457-461. [CrossRef]
29. Jian, P.W.; Aluko, R.E.; Nakai, S. Structural Requirements of Angiotensin I-Converting Enzyme Inhibitory Peptides: Quantitative Structure-Activity Relationship Study of Di-And Tripeptides. J. Agric. Food Chem. 2006, 54, 732-738.
30. Sato, M.; Hosokawa, T.; Yamaguchi, T.; Nakano, T.; Muramoto, K.; Kahara, T.; Funayama, K.; Kobayashi, A.; Nakano, T. Angiotensin I-converting enzyme inhibitory peptides derived from wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J. Agric. Food Chem. 2002, 50, 6245-6252. [CrossRef] [PubMed]
31. Suetsuna, K. Purification and identification of angiotensin I-converting enzyme inhibitors from the red alga Porphyra yezoensis. J. Mar. Biotechnol. 1998, 6, 163-167. [PubMed]
32. Suetsuna, K.; Chen, J.-R. Identification of Antihypertensive Peptides from Peptic Digest of Two Microalgae, Chlorella vulgaris and Spirulina platensis. Mar. Biotechnol. 2001, 3, 305-309. [CrossRef] [PubMed]
33. Kohama, Y.; Matsumoto, S.; Oka, H.; Teramoto, T.; Okabe, M.; Mimura, T. Isolation of angiotensin-converting enzyme inhibitor from tuna muscle. Biochem. Biophys. Res. Commun. 1988, 155, 332-337. [CrossRef]
34. Matsumura, N.; Fujii, M.; Takeda, Y.; Sugita, K.; Shimizu, T. Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci. Biotechnol. Biochem. 1993, 57, 695-697. [CrossRef] [PubMed]
35. Kim, S.-K.; Kim, Y.-T.; Byun, H.-G.; Nam, K.-S.; Joo, D.-S.; Shahidi, F. Isolation and characterization of antioxidative peptides from gelatin hydrolysate of Alaska pollack skin. J. Agric. Food Chem. 2001, 49, 1984-1989. [CrossRef] [PubMed]
36. Ono, S.; Hosokawa, M.; Miyashita, K.; Takahashi, K. Isolation of Peptides with Angiotensin I-converting Enzyme Inhibitory Effect Derived from Hydrolysate of Upstream Chum Salmon Muscle. J. Food Sci. 2003, 68, 1611-1614. [CrossRef]
37. Enari, H.; Takahashi, Y.; Kawarasaki, M.; Tada, M.; Tatsuta, K. Identification of angiotensin I-converting enzyme inhibitory peptides derived from salmon muscle and their antihypertensive effect. Fish. Sci. 2008, 74, 911-920. [CrossRef]
38. Ngo, D.-H.; Kang, K.-H.; Ryu, B.; Vo, T.-S.; Jung,W.-K.; Byun, H.-G.; Kim, S.-K. Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats. Food Chem. 2015, 174, 37-43. [CrossRef] [PubMed]
39. García-Moreno, P.J.; Espejo-Carpio, F.J.; Guadix, A.; Guadix, E.M. Production and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides from Mediterranean fish discards. J. Funct. Foods 2015, 18, 95-105. [CrossRef]
40. He, H.L.; Chen, X.L.; Sun, C.Y.; Zhang, Y.Z.; Zhou, B.C. Analysis of novel angiotensin 1 converting enzyme inhibitory peptides from protease-hydrolyzed marine shrimp Acetes chinensis. J. Pept. Sci. 2006, 12, 726-733.
41. Wang, Y.-K.; He, H.-L.; Chen, X.-L.; Sun, C.-Y.; Zhang, Y.-Z.; Zhou, B.-C. Production of novel angiotensin I-converting enzyme inhibitory peptides by fermentation of marine shrimp Acetes chinensis with Lactobacillus fermentum SM 605. Appl. Microbiol. Biotechnol. 2008, 79, 785-791. [CrossRef] [PubMed]
42. Cao, W.; Zhang, C.; Hong, P.; Ji, H.; Hao, J. Purification and identification of an ACE inhibitory peptide from the peptic hydrolysate of Acetes chinensis and its antihypertensive effects in spontaneously hypertensive rats. Int. J. Food Sci. Technol. 2010, 45, 959-965. [CrossRef]
43. Nii, Y.; Fukuta, K.; Yoshimoto, R.; Sakai, K.; Ogawa, T. Determination of antihypertensive peptides from an izumi shrimp hydrolysate. Biosci. Biotechnol. Biochem. 2008, 72, 861-864. [CrossRef] [PubMed]
44. Liu, X.; Zhang, M.; Jia, A.; Zhang, Y.; Zhu, H.; Zhang, C.; Sun, Z.; Liu, C. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from jellyfish Rhopilema esculentum. Food Res. Int. 2013, 50, 339-343. [CrossRef]
45. Du, L.; Fang, M.;Wu, H.; Xie, J.;Wu, Y.; Li, P.; Zhang, D.; Huang, Z.; Xia, Y.; Zhou, L. A novel angiotensin I-converting enzyme inhibitory peptide from Phascolosoma esculenta water-soluble protein hydrolysate. J. Funct. Foods 2013, 5, 475-483. [CrossRef]
46. Suetsuna, K. Identification of antihypertensive peptides from peptic digest of the short-necked clam Tapes philippinarum and the pearl oyster Pinctada fucata martensii. Fish. Sci. 2002, 68, 233-235. [CrossRef]
47. Fujita, H.; Yamagami, T.; Ohshima, K. Effects of an ACE-inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr. Res. 2001, 21, 1149-1158. [CrossRef]
48. Fujita, H.; Yoshikawa, M. LKPNM: A prodrug-Type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 1999, 44, 123-127. [CrossRef]
49. Kouno, K.; Hirano, S.-I.; Kuboki, H.; Kasai, M.; Hatae, K. Effects of Dried Bonito (Katsuobushi) and Captopril, an Angiotensin I-Converting Enzyme Inhibitor, on Rat Isolated Aorta: A Possible Mechanism of Antihypertensive Action. Biosci. Biotechnol. Biochem. 2005, 69, 911-915. [CrossRef] [PubMed]
50. Lee, J.K.; Jeon, J.-K.; Byun, H.-G. Antihypertensive effect of novel angiotensin I converting enzyme inhibitory peptide from chum salmon (Oncorhynchus keta) skin in spontaneously hypertensive rats. J. Funct. Foods 2014, 7, 381-389. [CrossRef]
51. Lee, S.-H.; Qian, Z.-J.; Kim, S.-K. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chem. 2010, 118, 96-102. [CrossRef]
52. Ko, S.-C.; Kang, N.; Kim, E.-A.; Kang, M.C.; Lee, S.-H.; Kang, S.-M.; Lee, J.-B.; Jeon, B.-T.; Kim, S.-K.; Park, S.-J. A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from a marine Chlorella ellipsoidea and its antihypertensive effect in spontaneously hypertensive rats. Proc. Biochem. 2012, 47, 2005-2011. [CrossRef]
53. Roy, M.; Mukherjee, A.; Sarkar, R.; Mukherjee, S.; Biswas, J. In search of natural remediation for cervical cancer. Anti-Cancer Agents Med. Chem. 2015, 15, 57-65. [CrossRef]
54. He, G.; Karin, M. NF-κB and STAT3-Key players in liver inflammation and cancer. Cell Res. 2011, 21, 159-168. [CrossRef] [PubMed]
55. Hall, E.; Cameron, D.; Waters, R.; Barrett-Lee, P.; Ellis, P.; Russell, S.; Bliss, J.; Hopwood, P.; Investigators, T.T. Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001). Eur. J. Cancer 2014, 50, 2375-2389. [CrossRef] [PubMed]
56. Kim, S.-K.; Kalimuthu, S. Introduction to Anticancer Drugs from Marine Origin. In Handbook of Anticancer Drugs from Marine Origin; Springer: Berlin, Germany, 2015; pp. 1-13.
57. Zheng, L.-H.; Wang, Y.-J.; Sheng, J.; Wang, F.; Zheng, Y.; Lin, X.-K.; Sun, M. Antitumor peptides from marine organisms. Mar. Drugs 2011, 9, 1840-1859. [CrossRef] [PubMed]
58. Cheung, R.C.F.; Ng, T.B.;Wong, J.H. Marine peptides: Bioactivities and applications. Mar. Drugs 2015, 13, 4006-4043. [CrossRef] [PubMed]
59. Crews, P.; Manes, L.V.; Boehler, M. Jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis sp. Tetrahedron Lett. 1986, 27, 2797-2800. [CrossRef]
60. Takeuchi, H.; Ara, G.; Sausville, A.E.; Teicher, B. Jasplakinolide: Interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma. Cancer Chemother. Pharmacol. 1998, 42, 491-496. [CrossRef] [PubMed]
61. Robinson, S.J.; Morinaka, B.I.; Amagata, T.; Tenney, K.; Bray, W.M.; Gassner, N.C.; Lokey, R.S.; Crews, P. New Structures and Bioactivity Properties of Jasplakinolide (Jaspamide) Analogues from Marine Sponges. J. Med. Chem. 2010, 53, 1651-1661. [CrossRef] [PubMed]
62. Rangel, M.; Prado, M.P.; Konno, K.; Naoki, H.; Freitas, J.C.; Machado-Santelli, G.M. Cytoskeleton alterations induced by Geodia corticostylifera depsipeptides in breast cancer cells. Peptides 2006, 27, 2047-2057. [CrossRef] [PubMed]
63. Freitas, V.M.; Rangel, M.; Bisson, L.F.; Jaeger, R.G.; Machado-Santelli, G.M. The geodiamolide H, derived from Brazilian sponge Geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment. J. Cell. Physiol. 2008, 216, 583-594. [CrossRef] [PubMed]
64. Chatterjee, J.; Rechenmacher, F.; Kessler, H. N-Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions. Angew. Chem. Int. Ed. 2013, 52, 254-269. [CrossRef] [PubMed]
65. Tran, T.D.; Pham, N.B.; Fechner, G.A.; Hooper, J.N.; Quinn, R.J. Potent cytotoxic peptides from the Australian marine sponge Pipestela candelabra. Mar. Drugs 2014, 12, 3399-3415. [CrossRef] [PubMed]
66. Kobayashi, M.; Aoki, S.; Ohyabu, N.; Kurosu, M.; Wang,W.; Kitagawa, I. Arenastatin A, a potent cytotoxic depsipeptide from the okinawan marine sponge Dysidea arenaria. Tetrahedron Lett. 1994, 35, 7969-7972. [CrossRef]
67. Silva, M.A.D.; Bierhalz, A.C.K.; Kieckbusch, T.G. Alginate and pectin composite films crosslinked with Ca2+ ions: Effect of the plasticizer concentration. Carbohydr. Polym. 2009, 77, 736-742. [CrossRef]
68. Murakami, N.; Tamura, S.; Koyama, K.; Sugimoto, M.; Maekawa, R.; Kobayashi, M. New analogue of arenastatin A, a potent cytotoxic spongean depsipeptide, with anti-Tumor activity. Bioorg. Med. Chem. Lett. 2004, 14, 2597-2601. [CrossRef] [PubMed]
69. Pettit, G.R.; Tan, R. Isolation and Structure of Phakellistatin 14 from the Western Pacific Marine Sponge Phakellia sp. 1. J. Nat. Prod. 2005, 68, 60-63. [CrossRef] [PubMed]
70. Li, W.-L.; Yi, Y.-H.; Wu, H.-M.; Xu, Q.-Z.; Tang, H.-F.; Zhou, D.-Z.; Lin, H.-W.; Wang, Z.-H. Isolation and Structure of the Cytotoxic Cycloheptapeptide Phakellistatin 13. J. Nat. Prod. 2003, 66, 146-148. [CrossRef] [PubMed]
71. Pettit, G.R.; Tan, R.; Ichihara, Y.; Williams, M.D.; Doubek, D.L.; Tackett, L.P.; Schmidt, J.M.; Cerny, R.L.; Boyd, M.R.; Hooper, J.N. Antineoplastic agents, 325. Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 from Phakellia sp. J. Nat. Prod. 1995, 58, 961-965. [CrossRef] [PubMed]
72. Pettit, G.R.; Xu, J.-P.; Dorsaz, A.-C.; Williams, M.D.; Boyd, M.R.; Cerny, R.L. Isolation and structure of the human cancer cell growth inhibitory cyclic decapeptides phakellistatins 7, 8 and 9 1, 2. Bioorg. Med. Chem. Lett. 1995, 5, 1339-1344. [CrossRef]
73. Pelay-Gimeno, M.; Meli, A.; Tulla-Puche, J.; Albericio, F. Rescuing biological activity from synthetic phakellistatin 19. J. Med. Chem. 2013, 56, 9780-9788. [CrossRef] [PubMed]
74. Zhan, K.-X.; Jiao,W.-H.; Yang, F.; Li, J.;Wang, S.-P.; Li, Y.-S.; Han, B.-N.; Lin, H.-W. Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis. J. Nat. Prod. 2014, 77, 2678-2684. [CrossRef] [PubMed]
75. Edrada-Ebel, R.; Jaspars, M. The 9th European Conference on Marine Natural Products. Mar. Drugs 2015, 13, 7150-7249. [CrossRef] [PubMed]
76. Ernst, E.; Consortium, C.C. Shark Cartilage: Concerted Action for Complementary and Alternative Medicine Assessment in the Cancer Field (CAM-Cancer); NAFKAM: Tromsø, Norway, 2013; pp. 1-53.
77. Ulbricht, C.; Hammerness, P.; Barrette, E.-P.; Boon, H.; Szapary, P.; Sollars, D.; Smith, M.; Tsouronis, C.; Bent, S. Shark cartilage monograph: A clinical decision support tool. J. Herb. Pharmacother. 2002, 2, 71-93. [CrossRef]
78. Dupont, E.; Falardeau, P.; Mousa, S.A.; Dimitriadou, V.; Pepin, M.-C.; Wang, T.; Alaoui-Jamali, M.A. Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue. Clin. Exp. Metastasis 2002, 19, 145-153. [CrossRef] [PubMed]
79. Gingras, D.; Boivin, D.; Deckers, C.; Gendron, S.; Barthomeuf, C.; Béliveau, R. Neovastat-A novel antiangiogenic drug for cancer therapy. Anti-Cancer Drugs 2003, 14, 91-96. [CrossRef] [PubMed]
80. Dredge, K. AE-941 (AEterna). Curr. Opin. Investig. Drugs 2004, 5, 668-677. [PubMed]
81. Zheng, L.; Ling, P.;Wang, Z.; Niu, R.; Hu, C.; Zhang, T.; Lin, X. A novel polypeptide from shark cartilage with potent anti-Angiogenic activity. Cancer Biol. Ther. 2007, 6, 775-780. [CrossRef] [PubMed]
82. Chen, J.-Y.; Lin,W.-J.;Wu, J.-L.; Her, G.M.; Hui, C.-F. Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells. Peptides 2009, 30, 2365-2373. [CrossRef] [PubMed]
83. Lin, W.-J.; Chien, Y.-L.; Pan, C.-Y.; Lin, T.-L.; Chen, J.-Y.; Chiu, S.-J.; Hui, C.-F. Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells. Peptides 2009, 30, 283-290. [CrossRef] [PubMed]
84. Hsu, K.-C.; Li-Chan, E.C.; Jao, C.-L. Antiproliferative activity of peptides prepared from enzymatic hydrolysates of tuna dark muscle on human breast cancer cell line MCF-7. Food Chem. 2011, 126, 617-622. [CrossRef]
85. Song, R.;Wei, R.-B.; Luo, H.-Y.; Yang, Z.-S. Isolation and identification of an antiproliferative peptide derived from heated products of peptic hydrolysates of half-fin anchovy (Setipinna taty). J. Funct. Foods 2014, 10, 104-111. [CrossRef]
86. Wang, M.; Nie, Y.; Peng, Y.; He, F.; Yang, J.; Wu, C.; Li, X. Purification, characterization and antitumor activities of a new protein from Syngnathus acus, an officinal marine fish. Mar. Drugs 2011, 10, 35-50. [CrossRef] [PubMed]
87. Freitas-Júnior, A.C.; Costa, H.M.; Icimoto, M.Y.; Hirata, I.Y.; Marcondes, M.; Carvalho, L.B.; Oliveira, V.; Bezerra, R.S. Giant Amazonian fish pirarucu (Arapaima gigas): Its viscera as a source of thermostable trypsin. Food Chem. 2012, 133, 1596-1602. [CrossRef]
88. Shai, Y.; Fox, J.; Caratsch, C.; Shih, Y.-L.; Edwards, C.; Lazarovici, P. Sequencing and synthesis of pardaxin, a polypeptide from the Red Sea Moses sole with ionophore activity. FEBS Lett. 1988, 242, 161-166. [CrossRef]
89. Huang, T.-C.; Lee, J.-F.; Chen, J.-Y. Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT-1080 cells. Mar. Drugs 2011, 9, 1995-2009. [CrossRef] [PubMed]
90. Boivin, D.; Gendron, S.; Beaulieu, É.; Gingras, D.; Béliveau, R. The Antiangiogenic Agent Neovastat (æ-941) Induces Endothelial Cell Apoptosis 1 Supported by æterna Laboratories, Québec City, Québec, Canada. 1. Mol. Cancer Ther. 2002, 1, 795-802. [PubMed]
91. Oren, Z.; Shai, Y. A Class of Highly Potent Antibacterial Peptides Derived from Pardaxin, A Pore-Forming Peptide Isolated from Moses Sole Fish Pardachirus marmoratus. Eur. J. Biochem. 1996, 237, 303-310. [CrossRef] [PubMed]
92. Hsu, J.-C.; Lin, L.-C.; Tzen, J.T.; Chen, J.-Y. Pardaxin-induced apoptosis enhances antitumor activity in HeLa cells. Peptides 2011, 32, 1110-1116. [CrossRef] [PubMed]
93. Pan, C.-Y.; Lin, C.-N.; Chiou, M.-T.; Yu, C.Y.; Chen, J.-Y.; Chien, C.-H. The antimicrobial peptide pardaxin exerts potent anti-Tumor activity against canine perianal gland adenoma. Oncotarget 2015, 6, 2290-2301. [CrossRef] [PubMed]
94. Han, Y.; Cui, Z.; Li, Y.-H.; Hsu, W.-H.; Lee, B.-H. In vitro and in vivo anticancer activity of pardaxin against proliferation and growth of oral squamous cell carcinoma. Mar. Drugs 2015, 14, 2. [CrossRef] [PubMed]
95. Mukherjee, A.K.; Saviola, A.J.; Burns, P.D.; Mackessy, S.P. Apoptosis induction in human breast cancer (MCF-7) cells by a novel venom L-Amino acid oxidase (Rusvinoxidase) is independent of its enzymatic activity and is accompanied by caspase-7 activation and reactive oxygen species production. Apoptosis 2015, 20, 1358-1372. [CrossRef] [PubMed]
96. Food and Agriculture Organization (FAO). The State of World Fisheries and Aquaculture 2016; FAO: Roma, Italy, 2016; p. 200.
97. Boutayeb, A.; Boutayeb, S. The burden of non communicable diseases in developing countries. Int. J. Equity Health 2005, 4, 2. [CrossRef] [PubMed]
98. Tahergorabi, R.; Jaczynski, J. Isoelectric solubilization/precipitation as a means to recover protein and lipids from seafood by-products. In Seafood Processing By-Products; Springer: New York, NY, USA, 2014; pp. 101-123.
99. Schwartsmann, G.; da Rocha, A.B.; Berlinck, R.G.; Jimeno, J. Marine organisms as a source of new anticancer agents. Lancet Oncol. 2001, 2, 221-225. [CrossRef]
100. Cain, J.M.; Liu, P.; Alberts, D.E.; Gallion, H.H.; Laufman, L.; O'Sullivan, J.;Weiss, G.; Bickers, J.N. Phase II trial of didemnin-B in advanced epithelial ovarian cancer. Investig. New Drugs 1992, 10, 23-24. [CrossRef]
101. Urdiales, J.; Morata, P.; De Castro, I.N.; Sánchez-Jiménez, F. Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett. 1996, 102, 31-37. [CrossRef]
102. Suarez-Jimenez, G.-M.; Burgos-Hernandez, A.; Ezquerra-Brauer, J.-M. Bioactive peptides and depsipeptides with anticancer potential: Sources from marine animals. Mar. Drugs 2012, 10, 963-986. [CrossRef] [PubMed]
103. Kucuk, O.; Young, M.L.; Habermann, T.M.; Wolf, B.C.; Jimeno, J.; Cassileth, P.A. Phase II Trial of Didemnin B in Previously Treated Non-Hodgkin's Lymphoma: An Eastern Cooperative Oncology Group (ECOG) Study. Am. J. Clin. Oncol. 2000, 23, 273-277. [CrossRef] [PubMed]
104. Da Rocha, A.B.; Lopes, R.M.; Schwartsmann, G. Natural products in anticancer therapy. Curr. Opin. Pharmacol. 2001, 1, 364-369. [CrossRef]
105. Cooper, E.L.; Albert, R. Tunicates: A vertebrate ancestral source of antitumor compounds. In Handbook of Anticancer Drugs from Marine Origin; Springer: Berlin, Germany, 2015; pp. 383-395.
106. Broggini, M.; Marchini, S.; Galliera, E.; Borsotti, P.; Taraboletti, G.; Erba, E.; Sironi, M.; Jimeno, J.; Faircloth, G.; Giavazzi, R. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cellsMOLT-4. Leukemia 2003, 17, 52-59. [CrossRef] [PubMed]
107. Kitagaki, J.; Shi, G.; Miyauchi, S.; Murakami, S.; Yang, Y. Cyclic depsipeptides as potential cancer therapeutics. Anti-Cancer Drugs 2015, 26, 259-271. [CrossRef] [PubMed]
108. Vervoort, H.; Fenical, W.; Epifanio, R.D.A. Tamandarins A and B: New cytotoxic depsipeptides from a Brazilian ascidian of the family Didemnidae. J. Org. Chem. 2000, 65, 782-792. [CrossRef] [PubMed]
109. Blanco-Míguez, A.; Gutiérrez-Jácome, A.; Pérez-Pérez, M.; Pérez-Rodríguez, G.; Catalán-García, S.; Fdez-Riverola, F.; Lourenço, A.; Sánchez, B. From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides. Protein Sci. 2016, 25, 1084-1095. [CrossRef] [PubMed]
110. Bowden, B.; Gravalos, D.G. Cyclic Hepta-Peptide Derivative from Colonial Ascidians, Lissoclinum sp. U.S. Patent No. US 20040033940 A1, 3 April 2004.
111. Kalemkerian, P.G.; Ou, X.; Adil, R.M.; Rosati, R.; Khoulani, M.M.; Madan, K.S.; Pettit, R.G. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: Induction of apoptosis and bcl-2 modification. Cancer Chemother. Pharmacol. 1999, 43, 507-515. [CrossRef] [PubMed]
112. Aneiros, A.; Garateix, A. Bioactive peptides from marine sources: Pharmacological properties and isolation procedures. J. Chromatogr. B 2004, 803, 41-53. [CrossRef] [PubMed]
113. Margolin, K.; Longmate, J.; Synold, T.W.; Gandara, D.R.; Weber, J.; Gonzalez, R.; Johansen, M.J.; Newman, R.; Baratta, T.; Doroshow, J.H. Dolastatin-10 in Metastatic Melanoma: A Phase II and Pharmokinetic Trial of the California Cancer Consortium. Investig. New Drugs 2001, 19, 335-340. [CrossRef]
114. Turner, T.; Jackson,W.H.; Pettit, G.R.;Wells, A.; Kraft, A.S. Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc. Prostate 1998, 34, 175-181. [CrossRef]
115. Zheng, L.; Lin, X.;Wu, N.; Liu, M.; Zheng, Y.; Sheng, J.; Ji, X.; Sun, M. Targeting cellular apoptotic pathway with peptides from marine organisms. BBA Rev. Cancer 2013, 1836, 42-48. [CrossRef] [PubMed]
116. Liu, M.; Zhao, X.; Zhao, J.; Xiao, L.; Liu, H.; Wang, C.; Cheng, L.; Wu, N.; Lin, X. Induction of apoptosis, G0/G1 phase arrest and microtubule disassembly in K562 leukemia cells by Mere15, a novel polypeptide from Meretrix meretrix Linnaeus. Mar. Drugs 2012, 10, 2596-2607. [CrossRef] [PubMed]
117. Wang, H.;Wei, J.;Wu, N.; Liu, M.;Wang, C.; Zhang, Y.;Wang, F.; Liu, H.; Lin, X. Mere15, a novel polypeptide from Meretrix meretrix, inhibits adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMPs. Pharm. Biol. 2013, 51, 145-151. [CrossRef] [PubMed]
118. Janmaat, M.L.; Rodriguez, J.A.; Jimeno, J.; Kruyt, F.A.; Giaccone, G. Kahalalide F induces necrosis-like cell death that involves depletion of ErbB3 and inhibition of Akt signaling. Mol. Pharmacol. 2005, 68, 502-510. [CrossRef] [PubMed]
119. Wang, B.; Waters, A.L.; Valeriote, F.A.; Hamann, M.T. An efficient and cost-effective approach to kahalalide F N-Terminal modifications using a nuisance algal bloom of Bryopsis pennata. Biochim. Biophys. Acta 2015, 1850, 1849-1854. [CrossRef] [PubMed]
120. Staats, P.S.; Yearwood, T.; Charapata, S.G.; Presley, R.W.;Wallace, M.S.; Byas-Smith, M.; Fisher, R.; Bryce, D.A.; Mangieri, E.A.; Luther, R.R. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial. JAMA 2004, 291, 63-70. [CrossRef] [PubMed]
121. Olivier Brenet, M.; Sabine de Bourmont, M.; Florence Dixmerias, M.; Nadia Buisset, M.; Nathalie Lebrec, M.; Dominique Monnin, M. Ziconotide adverse events in patients with cancer pain: A multicenter observational study of a slow titration, multidrug protocol. Pain Phys. 2012, 15, 395-403.
122. Mundt, S.; Kreitlow, S.; Nowotny, A.; Effmert, U. Biochemical and pharmacological investigations of selected cyanobacteria. Int. J. Hyg. Environ. Health 2001, 203, 327-334. [CrossRef] [PubMed]
123. Thornburg, C.C.; Thimmaiah, M.; Shaala, L.A.; Hau, A.M.; Malmo, J.M.; Ishmael, J.E.; Youssef, D.T.; McPhail, K.L. Cyclic depsipeptides, grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium. J. Nat. Prod. 2011, 74, 1677-1685. [CrossRef] [PubMed]
124. Do Rosário Martins, M.; Costa, M. Marine Cyanobacteria Compounds with Anticancer Properties: Implication of Apoptosis. In Handbook of Anticancer Drugs from Marine Origin; Kim, S.-K., Ed.; Springer: Cham, Germany, 2015; pp. 621-647.
125. Shaala, L.A.; Youssef, D.T.; McPhail, K.L.; Elbandy, M. Malyngamide 4, a new lipopeptide from the Red Sea marine cyanobacterium Moorea producens (formerly Lyngbya majuscula). Phytochem. Lett. 2013, 6, 183-188. [CrossRef]
126. Wrasidlo,W.; Mielgo, A.; Torres, V.A.; Barbero, S.; Stoletov, K.; Suyama, T.L.; Klemke, R.L.; Gerwick,W.H.; Carson, D.A.; Stupack, D.G. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc. Natl. Acad. Sci. USA 2008, 105, 2313-2318. [CrossRef] [PubMed]
127. Marquez, B.L.;Watts, K.S.; Yokochi, A.; Roberts, M.A.; Verdier-Pinard, P.; Jimenez, J.I.; Hamel, E.; Scheuer, P.J.; Gerwick, W.H. Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. J. Nat. Prod. 2002, 65, 866-871. [CrossRef] [PubMed]
128. Luesch, H.; Chanda, S.K.; Raya, R.M.; DeJesus, P.D.; Orth, A.P.;Walker, J.R.; Belmonte, J.C.I.; Schultz, P.G. A functional genomics approach to the mode of action of apratoxin A. Nat. Chem. Biol. 2006, 2, 158-167. [CrossRef] [PubMed]
129. Singh, R.K.; Tiwari, S.P.; Rai, A.K.; Mohapatra, T.M. Cyanobacteria: An emerging source for drug discovery. J. Antibiot. 2011, 64, 401-412. [CrossRef] [PubMed]
130. Li, B.; Gao, M.H.; Zhang, X.C.; Chu, X.M. Molecular immune mechanism of c-phycocyanin from Spirulina platensis induces apoptosis in HeLa cells in vitro. Biotechnol. Appl. Biochem. 2006, 43, 155-164. [PubMed]
131. Thangam, R.; Suresh, V.; Princy, W.A.; Rajkumar, M.; SenthilKumar, N.; Gunasekaran, P.; Rengasamy, R.; Anbazhagan, C.; Kaveri, K.; Kannan, S. C-Phycocyanin from Oscillatoria tenuis exhibited an antioxidant and in vitro antiproliferative activity through induction of apoptosis and G0/G1 cell cycle arrest. Food Chem. 2013, 140, 262-272. [CrossRef] [PubMed]
132. Lau, N.-S.; Matsui, M.; Abdullah, A.A.-A. Cyanobacteria: Photoautotrophic microbial factories for the sustainable synthesis of industrial products. BioMed Res. Int. 2015, 2015, 754934. [CrossRef] [PubMed]
133. Ngo, D.H.; Wijesekara, I.; Vo, T.S.; Van Ta, Q.; Kim, S.K. Marine food-derived functional ingredients as potential antioxidants in the food industry: An overview. Food Res. Int. 2011, 44, 523-529. [CrossRef]
134. Nazeer, R.; Prabha, K.D.; Kumar, N.S.; Ganesh, R.J. Isolation of antioxidant peptides from clam, Meretrix casta (Chemnitz). J. Food Sci. Technol. 2013, 50, 777-783. [CrossRef] [PubMed]
135. Rajapakse, N.; Mendis, E.; Byun, H.-G.; Kim, S.-K. Purification and in vitro antioxidative effects of giant squid muscle peptides on free radical-mediated oxidative systems. J. Nutr. Biochem. 2005, 16, 562-569. [CrossRef] [PubMed]
136. Shahidi, F.; Zhong, Y. Bioactive Peptides. J. AOAC Int. 2008, 91, 914-931. [PubMed]
137. Je, J.-Y.; Park, P.-J.; Kim, S.-K. Antioxidant activity of a peptide isolated from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. Food Res. Int. 2005, 38, 45-50. [CrossRef]
138. Jun, S.-Y.; Park, P.-J.; Jung,W.-K.; Kim, S.-K. Purification and characterization of an antioxidative peptide from enzymatic hydrolysate of yellowfin sole (Limanda aspera) frame protein. Eur. Food Res. Technol. 2004, 219, 20-26.
139. Mendis, E.; Rajapakse, N.; Kim, S.-K. Antioxidant properties of a radical-scavenging peptide purified from enzymatically prepared fish skin gelatin hydrolysate. J. Agric. Food Chem. 2005, 53, 581-587. [CrossRef] [PubMed]
140. Himaya, S.; Ryu, B.; Ngo, D.-H.; Kim, S.-K. Peptide Isolated From Japanese Flounder Skin Gelatin Protects Against Cellular Oxidative Damage. J. Agric. Food Chem. 2012, 60, 9112-9119. [CrossRef] [PubMed]
141. Guérard, F.; Decourcelle, N.; Sabourin, C.; Floch-Laizet, C.; Le Grel, L.; Le Floc'H, P.; Gourlay, F.; Le Delezir, R.; Jaouen, P.; Bourseau, P. Recent developments of marine ingredients for food and nutraceutical applications: A review. J. Sci. Halieut. Aquat. 2010, 2, 21-27.
142. Zhu, C.-F.; Peng, H.-B.; Liu, G.-Q.; Zhang, F.; Li, Y. Beneficial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes. Nutrition 2010, 26, 1014-1020. [CrossRef] [PubMed]
143. Zhu, C.-F.; Li, G.-Z.; Peng, H.-B.; Zhang, F.; Chen, Y.; Li, Y. Effect of marine collagen peptides on markers of metabolic nuclear receptors in type 2 diabetic patients with/without hypertension. Biomed. Environ. Sci. 2010, 23, 113-120. [CrossRef]
144. Zhu, C.-F.; Li, G.-Z.; Peng, H.-B.; Zhang, F.; Chen, Y.; Li, Y. Treatment with marine collagen peptides modulates glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitus. Appl. Physiol. Nutr. Metab. 2010, 35, 797-804. [CrossRef] [PubMed]
145. Chance, W.T.; Tao, Z.; Sheriff, S.; Balasubramaniam, A. WRYamide, A NPY-based tripeptide that antagonizes feeding in rats. Brain Res. 1998, 803, 39-43. [CrossRef]
146. Vernaleken, A.; Veyhl, M.; Gorboulev, V.; Kottra, G.; Palm, D.; Burckhardt, B.-C.; Burckhardt, G.; Pipkorn, R.; Beier, N.; van Amsterdam, C. Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity. J. Biol. Chem. 2007, 282, 28501-28513. [CrossRef] [PubMed]
147. Chevrier, G.; Mitchell, P.L.; Rioux, L.-E.; Hasan, F.; Jin, T.; Roblet, C.R.; Doyen, A.; Pilon, G.; St-Pierre, P.; Lavigne, C. Low-molecular-weight peptides from salmon protein prevent obesity-linked glucose intolerance, inflammation, and dyslipidemia in LDLR//ApoB100/100 mice. J. Nutr. 2015, 145, 1415-1422. [CrossRef] [PubMed]
148. Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004, 25, 4-7. [CrossRef] [PubMed]
149. Nagaoka, S.; Shimizu, K.; Kaneko, H.; Shibayama, F.; Morikawa, K.; Kanamaru, Y.; Otsuka, A.; Hirahashi, T.; Kato, T. A novel protein c-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J. Nutr. 2005, 135, 2425-2430. [PubMed]
150. Colla, L.M.; Muccillo-Baisch, A.L.; Costa, J.A.V. Spirulina platensis effects on the levels of total cholesterol, HDL and triacylglycerols in rabbits fed with a hypercholesterolemic diet. Braz. Arch. Biol. Technol. 2008, 51, 405-411. [CrossRef]
151. Lordan, S.; Ross, R.P.; Stanton, C. Marine Bioactives as Functional Food Ingredients: Potential to Reduce the Incidence of Chronic Diseases. Mar. Drugs 2011, 9, 1056-1110. [CrossRef] [PubMed]
152. Craik, D.J.; Fairlie, D.P.; Liras, S.; Price, D. The future of peptide-based drugs. Chem. Biol. Drug Des. 2013, 81, 136-147. [CrossRef] [PubMed]
153. Shahidi, F.; Chandrasekara, A. Millet grain phenolics and their role in disease risk reduction and health promotion: A review. J. Funct. Foods 2013, 5, 570-581. [CrossRef]
154. Udenigwe, C.C.; Aluko, R.E. Food protein-derived bioactive peptides: Production, processing, and potential health benefits. J. Food Sci. 2012, 77, R11-R24. [CrossRef] [PubMed]
155. Zhuang, Y.; Sun, L.; Zhang, Y.; Liu, G. Antihypertensive Effect of Long-Term Oral Administration of Jellyfish (Rhopilema esculentum) Collagen Peptides on Renovascular Hypertension. Mar. Drugs 2012, 10, 417-426. [CrossRef] [PubMed]